Drugs / Oxygen
last change 10 days ago re-read 9 days ago

Oxygen

Other / unclassified

Developed for
chronic obstructive pulmonary disease · traumatic brain injury · migraine disorder · polycythemia due to hypoxia · acute coronary syndrome · bronchiolitis · coronary artery disorder · COVID-19
+87 more · critical illness polyneuropathy · idiopathic pulmonary fibrosis · interstitial lung disease · obstructive sleep apnea syndrome · pulmonary fibrosis · pulmonary hypertension · skin infection · ST-elevation myocardial infarction · acute respiratory failure · alternating hemiplegia of childhood · ampulla of vater neoplasm · ankle defects short stature · apnea of prematurity · articular cartilage disorder · avascular necrosis · branch retinal artery occlusion · breast cancer · calciphylaxis · cardiac arrest · cardiovascular disorder · central retinal vein occlusion · central sleep apnea syndrome · chronic cystitis · cluster headache syndrome · colonic pseudo-obstruction · Crohn disease · decompression sickness · decubitus ulcer · dermatitis · Ehlers-Danlos syndrome · enterocolitis · epidermolysis bullosa · fetal brain disruption sequence · fungal infectious disease · graft versus host disease · headache disorder · hypoplastic left heart syndrome · hypospadias · immune system disorder · inclusion body myositis · infectious disease with sepsis · inflammatory bowel disease · intermediate coronary syndrome · intestinal fistula · ischemic bowel disorder · ischemic disease · ligament disorder · malignant otitis externa · multiple sclerosis · nervous system disorder · neurodevelopmental disorder · non-arteritic anterior ischemic optic neuropathy · perinatal asphyxia · peripheral nerve lesion · pneumatosis cystoides intestinalis · post-COVID-19 disorder · pouchitis · prosthesis-related infectious disease · pterygium · pulmonary arterial hypertension · pulmonary embolism · pyoderma gangrenosum · radiation-induced disorder · Raynaud disease · respiratory failure · respiratory system disorder · retinitis pigmentosa · schizophrenia · tinnitus · traumatic encephalopathy · ulcer of anus and rectum · ulcerative colitis · vascular disorder · vasculitis · acute myocardial infarction · autoinflammatory syndrome · chronic thromboembolic pulmonary hypertension · congestive heart failure · heart failure · high altitude pulmonary edema · ischemic stroke · lumbar disk disease · middle lobe syndrome · pulmonary edema · pulmonary immaturity · respiratory distress syndrome in premature infants · sleep apnea syndrome
Investigated by
Medical University of Vienna · Insel Gruppe AG, University Hospital Bern · Karolinska Institutet · National Heart, Lung, and Blood Institute (NHLBI) · The Hospital for Sick Children · University of Zurich
+121 more · Centre Hospitalier Universitaire de Nice · China Medical University, China · Duke University · LHL Helse · Massachusetts General Hospital · Monash University · Nova Scotia Health Authority · Ottawa Hospital Research Institute · Rigshospitalet, Denmark · University Hospital Southampton NHS Foundation Trust · University Hospital, Linkoeping · University of Birmingham · University of Modena and Reggio Emilia · Aalborg University Hospital · Aarhus University Hospital · Air Force Military Medical University, China · Air Liquide · Air Liquide SA · Albert Einstein Healthcare Network · Alberta Boehringer Ingelheim Collaboration · Ambulance Victoria · American Heart Association · Asklepios Kliniken Hamburg GmbH · Assistance Publique - Hôpitaux de Paris · Barry Miskin, MD · Baskent University Ankara Hospital · Beersheva Mental Health Center · Brigham and Women's Hospital · Case Western Reserve University · Centers for Medicare and Medicaid Services · Central Denmark Region · Climate Foundation · Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Copenhagen Trial Unit, Center for Clinical Intervention Research · Copenhagen University Hospital, Hvidovre · Curtin University · Dalhousie University · Dartmouth College · Emergency Medicine Foundation · Erzincan Military Hospital · Flinders University · Florida Hospital Tampa Bay Division · Fondation de France · Francisco Andres de la Gala · Guangzhou Jeeyor Medical Research Co.,Ltd. · Göteborg University · Heart Foundation of Australia · Heart of England NHS Trust · Hospital St. Joseph, Marseille, France · Hospitales Universitarios Virgen del Rocío · IRCCS Burlo Garofolo · Instituto de Salud Carlos III · Istanbul University - Cerrahpasa · James A. Haley Veterans' Hospital (JAHVH) · Jay C. Buckey Jr. · Jupiter Medical Center · KTH Royal Institute of Technology · L'effet Papillon · Lady Hardinge Medical College · Mahidol University · Makerere University · Mallinckrodt · McMaster University · Nantes University Hospital · National Alliance for Research on Schizophrenia and Depression · National Health Service, United Kingdom · National Institute for Health Research, United Kingdom · National Institute of General Medical Sciences (NIGMS) · Norwegian Air Ambulance Foundation · Nova Southeastern University · Ontario Ministry of Health and Long Term Care · Oslo University Hospital · Parc de Salut Mar · Patient-Centered Outcomes Research Institute · all 127 on the full record

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) OXYGEN, USP — 2013-06-16 fda.gov ↗

Trials 101 · started per year

today
US approved 2013
1
1
3
2
2
8
2
3
8
3
7
6
7
3
8
5
4
5
6
3
6
3
4
20032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 02 trials
Phase 0 NCT05891886 Oct 2023 → Jun 2027 expected pulmonary embolism, venous thromboembolism Massachusetts General Hospital Recruiting No outcome recorded
Phase 0 NCT02465749 May 2015 → Jun 2025 retinitis pigmentosa Sun Yat-sen University Unknown No outcome recorded
Phase 15 trials · 1 missed
Phase 1 NCT05150418 Nov 2021 → Jun 2022 dehydration polycythemia Oslo University Hospital Completed Missed primary
Phase 1 NCT06665633 Sep 2021 → Jul 2025 depressive disorder, traumatic brain injury Nova Southeastern University Completed No outcome recorded
Phase 1 NCT03511846 Mar 2018 → May 2028 expected SUNCT syndrome, cluster headache syndrome, hemicrania continua, migraine disorder +1 The University of Texas Health Science Center, Houston Enrolling by invitation No outcome recorded
Phase 1 NCT03386136 Jan 2018 → Oct 2019 colonic pseudo-obstruction University of Florida Completed No outcome recorded
Phase 1 NCT02286544 Oct 2014 → Dec 2015 acute coronary syndrome, myocardial infarction Karolinska Institutet Completed No outcome recorded
Phase 1/24 trials
Phase 1/2 NCT06327373 Jul 2026 → Jun 2027 pulmonary hypertension Duke University Withdrawn No outcome recorded Stop: Business
Phase 1/2 NCT06109961 Jan 2024 → Jan 2026 inflammatory bowel disease Ottawa Hospital Research Institute Unknown No outcome recorded
Phase 1/2 NCT03136835 Feb 2018 → Mar 2024 hypoplastic left heart syndrome The Hospital for Sick Children Completed No outcome recorded
Phase 1/2 NCT01847755 Apr 2013 → Dec 2020 traumatic brain injury Barry Miskin, MD Completed No outcome recorded
Phase 210 trials · 2 missed
Phase 2 NCT06053164 Jul 2025 → Sep 2026 overdue pulmonary fibrosis University of Alberta Recruiting No outcome recorded
Phase 2 NCT06248645 Sep 2024 → Mar 2026 alternating hemiplegia of childhood Assistance Publique - Hôpitaux de Paris Completed No outcome recorded
Phase 2 NCT04094285 Oct 2019 → Jul 2024 — Medical University of Vienna Completed No outcome recorded
Phase 2 NCT03189173 Sep 2017 → May 2023 obstructive sleep apnea syndrome Brigham and Women's Hospital Completed No outcome recorded
Phase 2 NCT02499042 Jul 2015 → Aug 2017 cardiac arrest Monash University Completed No outcome recorded
Phase 2 NCT02356900 Feb 2015 → May 2016 — Duke University Terminated No outcome recorded Stop: Enrollment
Phase 2 NCT01542307 Jul 2012 → Sep 2015 migraine disorder Massachusetts General Hospital Completed Missed primary
Phase 2 NCT02668029 Apr 2012 → Apr 2013 pulmonary fibrosis University of Siena Completed No outcome recorded
Phase 2 NCT01306968 Feb 2011 → Aug 2012 traumatic brain injury, traumatic encephalopathy U.S. Army Medical Research and Development Command Completed Missed primary
Phase 2 NCT01355809 Dec 2009 → Mar 2011 chronic obstructive pulmonary disease Air Liquide SA Terminated No outcome recorded Stop: Enrollment
Phase 2/34 trials · 1 missed
Phase 2/3 NCT04500626 Apr 2021 → Aug 2022 COVID-19 Ottawa Hospital Research Institute Unknown No outcome recorded
Phase 2/3 NCT03483194 Sep 2018 → Apr 2020 hematopoietic and lymphoid cell neoplasm Weprom Completed Missed primary
Phase 2/3 NCT02361944 Apr 2016 → Oct 2020 — Vanderbilt University Completed No outcome recorded
Phase 2/3 NCT02468752 May 2015 → Apr 2019 decompression sickness, nervous system injury Göteborg University Completed No outcome recorded
Phase 315 trials · 1 met primary · 2 missed
Phase 3 NCT06581003 Sep 2024 → Aug 2028 expected traumatic brain injury University of South Florida Recruiting No outcome recorded
Phase 3 NCT04597723 May 2022 → Jan 2023 — Selcuk University Unknown No outcome recorded
Phase 3 NCT05185115 Apr 2022 → Oct 2026 expected ankle defects short stature Nantes University Hospital Active not recruiting No outcome recorded
Phase 3 NCT05430620 Mar 2022 → Jan 2025 ischemic disease, mitochondrial disease Cliniques universitaires Saint-Luc- Université Catholique de Louvain Unknown No outcome recorded
Phase 3 NCT04256798 Nov 2020 → Oct 2025 overdue pneumonia, skin infection University of Birmingham Recruiting No outcome recorded
Phase 3 NCT04043299 Mar → Aug 2020 fetal brain disruption sequence, perinatal asphyxia Makerere University Unknown No outcome recorded
Phase 3 NCT04193722 Aug 2019 → May 2023 breast cancer, radiation-induced disorder UMC Utrecht Completed Missed primary
Phase 3 NCT02562781 Nov 2014 → Dec 2020 vascular disorder Örebro University, Sweden Completed No outcome recorded
Phase 3 NCT02290080 Oct 2014 → Dec 2015 ST-elevation myocardial infarction, acute coronary syndrome, intermediate coronary syndrome Karolinska Institutet Completed No outcome recorded
Phase 3 NCT01530971 Mar 2012 → Mar 2013 — Mahidol University Completed No outcome recorded
Phase 429 trials · 2 met primary · 2 missed
Phase 4 NCT07240649 Nov 2026 → Dec 2035 expected COVID-19, Crohn disease, Raynaud disease, articular cartilage disorder +30 Jay C. Buckey Jr. Not yet recruiting No outcome recorded
Phase 4 NCT07280468 Mar 2026 → Jan 2030 expected Down syndrome, obstructive sleep apnea syndrome University of Arizona Recruiting No outcome recorded
Phase 4 NCT05703919 Jun 2025 → Feb 2028 expected chronic obstructive pulmonary disease Central Denmark Region Recruiting No outcome recorded
Phase 4 NCT07461779 Jan 2025 → Dec 2026 expected — Francisco Andres de la Gala Recruiting No outcome recorded
Phase 4 NCT06359106 Jul 2024 → Jun 2026 overdue — China Medical University, China Recruiting No outcome recorded
Phase 4 NCT04925414 Oct 2023 → Apr 2025 overdue migraine disorder Centre Hospitalier Universitaire de Nice Recruiting No outcome recorded
Phase 4 NCT06013098 Sep 2023 → Jan 2026 — China Medical University, China Completed No outcome recorded
Phase 4 NCT05505032 Aug → Sep 2022 polycythemia due to hypoxia Baskent University Ankara Hospital Completed No outcome recorded
Phase 4 NCT04890431 Mar 2022 → Oct 2023 Ehlers-Danlos syndrome Hospital St. Joseph, Marseille, France Unknown No outcome recorded
Phase 4 NCT05146700 Dec 2021 → Oct 2023 — Rigshospitalet, Denmark Completed Missed primary
Phase not applicable32 trials · 1 met primary · 2 missed
— NCT07464730 Apr 2026 → Mar 2028 expected — Region Stockholm Recruiting No outcome recorded
— NCT06643403 Sep 2024 → Dec 2025 overdue — Medical University of Vienna Recruiting No outcome recorded
— NCT03800017 Aug 2024 → Dec 2026 expected hypersensitivity pneumonitis, idiopathic pulmonary fibrosis, non-specific interstitial pneumonia, scleroderma University of British Columbia Recruiting No outcome recorded
— NCT05427760 Oct 2022 → Mar 2023 dermatitis Istanbul University - Cerrahpasa Completed No outcome recorded
— NCT04808401 May 2021 → Dec 2027 expected coronary artery disorder Insel Gruppe AG, University Hospital Bern Recruiting No outcome recorded
— NCT04424433 Jun 2020 → Jun 2021 coronary artery disorder Insel Gruppe AG, University Hospital Bern Completed No outcome recorded
— NCT04564664 Mar 2019 → Dec 2020 idiopathic pulmonary fibrosis Parc de Salut Mar Completed No outcome recorded
— NCT03738722 Jan → Mar 2019 — Insel Gruppe AG, University Hospital Bern Completed No outcome recorded
— NCT03478774 Mar 2018 → Dec 2019 — Insel Gruppe AG, University Hospital Bern Completed No outcome recorded
— NCT03287466 Jan 2018 → Nov 2019 critical illness polyneuropathy, respiratory failure University College, London Completed No outcome recorded
Comparator or background therapy91 trials
Phase 1 NCT06740305 Background May → Aug 2025 decompression sickness Duke University Completed No outcome recorded
Phase 1 NCT02473354 Background Apr 2015 → Apr 2018 respiratory underresponsiveness to hypoxia and hypercapnia Duke University Completed No outcome recorded
Phase 1 NCT01298921 Comparator Jan 2011 → Jun 2012 cluster headache syndrome Geisinger Clinic Terminated No outcome recorded Stop: Enrollment
Phase 1 NCT01157624 Comparator May → Oct 2010 — University of Malaya Completed No outcome recorded
Phase 1/2 NCT02065947 Comparator Oct 2013 → Mar 2014 — Ramathibodi Hospital Completed No outcome recorded

Press releases naming this drug 1 release

DateIssuerRelease
2023-10-25 Xenothera SAS [Press Release] French biotech announces its therapeutic potential for oxygen-free patients xenothera.com ↗

Evidence & citations 27 cited values

Every value below carries the sentence it was read from. 195 sources stand behind the page.

FieldValueCited text
Known as Oxygen “Patients were randomized to receive either usual care, including conventional optimal treatment with furosemide, oxygen, and high-dose boluses of isosorbide dinitrate plus...” PMID 20825901 ↗ May 2010
183

“All patients will receive injectable paracetamol for pain relief, a mix of nitrous oxide 50% and oxygen 50% for analgesia and lidocaine hydrochloride for local anesthesia.” NCT02236260 ↗

“Patients are randomized between two daily durations of oxygen used in current clinical practice: LTOT 24 h/day (intervention) or 15 h/day (control).” NCT03441204 ↗

“Patients will be randomly assigned to receive either 100% oxygen by mask (treated group) or breath room air (control group).” NCT01448889 ↗

“Anesthesia is maintained by 1-1.5% sevoflurane, 0.5 µg/kg/h fentanyl, 0.05 mg/kg/h nimbex, 60% nitrous oxide and 40% oxygen.” NCT02534012 ↗

“administeration via inhalation of Nitrous oxide/oxygen (30-50% N2O/ 70-50% O2) via inhalation” NCT05126459 ↗

“Maintenance with sevoflurane 1-3%, fentanyl (1-2 µg kg-1), nitrous oxide 70% and oxygen 30%.” NCT02355678 ↗

“Inhalated gas, medicinal oxygen 100% via NIV with Fi O2 0.35, one time by random, 6 minutes” NCT01355809 ↗

“the concentration of intraoperative inspired fraction of oxygen is 80% oxygen + 20% air” NCT06108791 ↗

“Maintenance of anesthesia with sevoflurane, oxygen and air” NCT01511627 ↗

“60% nitrous oxide combined with 40% oxygen for ventilation” NCT00547209 ↗

Show 173 more sources

Known as 02 or Oxygen “02 or Oxygen” NCT01847755 ↗
Known as Air/Oxygen ClinicalTrials.gov intervention name — accepted as the source's own label NCT01155310 ↗
Known as Dioxygen ChEMBL registry synonym — accepted as the source's own label CHEMBL1234886 ↗
Known as E-948 ChEMBL registry synonym — accepted as the source's own label CHEMBL1234886 ↗
Known as Equimolar Mixture of Nitrogen Protoxide and Oxygen “Use of MEOPA (Equimolar Mixture of Nitrogen Protoxide and Oxygen) for Elderly With Dementia” NCT00822224 ↗
Known as INS NO.948 ChEMBL registry synonym — accepted as the source's own label CHEMBL1234886 ↗
Known as INS-948 ChEMBL registry synonym — accepted as the source's own label CHEMBL1234886 ↗
Known as Medicinal oxygen air liquide sante ChEMBL registry synonym — accepted as the source's own label CHEMBL1234886 ↗
Known as MEOPA ClinicalTrials.gov intervention name — accepted as the source's own label NCT00822224 ↗
Known as Molecular oxygen ChEMBL registry synonym — accepted as the source's own label CHEMBL1234886 ↗
Known as NBO “Subjects will be consented to inhale either Normobaric Oxygen (NBO) or Room air for 30 minutes at the start of their migraine attacks.” NCT01542307 ↗
Known as Normobaric Oxygen “Subjects will be consented to inhale either Normobaric Oxygen (NBO) or Room air for 30 minutes at the start of their migraine attacks.” NCT01542307 ↗
Known as O(2) “All patients were tested with each of three agents (80 ppm iNO, 100% O(2), combination of 80 ppm iNO/100% O(2)) in three 10-min treatment periods, and hemodynamic measurements obtained.” PMID 20405117 ↗ Apr 2010
3

NCT00431548 ↗

NCT03728894 ↗

NCT00431691 ↗

Known as Oxygen 93 percent ChEMBL registry synonym — accepted as the source's own label CHEMBL1234886 ↗
Known as OXYGEN COMPONENT OF RNS-60 ChEMBL registry synonym — accepted as the source's own label CHEMBL1234886 ↗
Known as Oxygen molecule ChEMBL registry synonym — accepted as the source's own label CHEMBL1234886 ↗
Known as Oxygen supplementation “Drug: Oxygen supplementation” NCT03683082 ↗
Known as Oxygen/nitrous oxide equimolar mix ClinicalTrials.gov intervention name — accepted as the source's own label NCT02573987 ↗
Known as Oxygenium ChEMBL registry synonym — accepted as the source's own label CHEMBL1234886 ↗
Known as Oxygène ClinicalTrials.gov intervention name — accepted as the source's own label NCT00643786 ↗
Known as PL 15929/005 “The IMP investigated in this study is medical oxygen (PL 15929/005), manufactured by Air Liquide Ltd. UK.” NCT02286063 ↗
Known as Premixed 50% nitrous oxide and oxygen ClinicalTrials.gov intervention name — accepted as the source's own label NCT01990404 ↗
Known as SAUERSTOFF ClinicalTrials.gov intervention name — accepted as the source's own label NCT04094285 ↗
Action Inhibit “100% oxygen or 0.5 MAC isoflurane/sevoflurane in 60% oxygen would inhibit increases of tumor necrosis factor (TNF)-alpha, interleukin-1beta, interleukin-6 in the cell culture...” NCT02185118 ↗